Long-term mechanical circulatory support has become a valid treatment option for end stage heart failure. In selected patients’ cases, this therapeutic option has been proven to improve survival, both as a bridge to transplant and as a destination therapy. In this article, we address implantation technique, strategies to prevent excessive bleeding, right heart failure, and driveline and pocket infection.Dugotrajna mehanička potpora cirkulaciji postala je provjerena metoda u liječenju završne faze srčanog zatajenja. Kod odabranih bolesnika, dokazano je da poboljšava preživljenje, bilo kao potpora do transplantacije ili destinacijske terapije. U članku opisujemo tehnike ugradnje, strategije u cilju smanjenja prekomjernog krvarenja, zatajenja ...
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. Th...
Heart transplant is the gold-standard treatment for end-stage heart failure. However, the aging of t...
Heart failure continues to be an ever-growing public health concern. The continued aging of the popu...
Heart failure is a clinical syndrome of multifactorial aetiology with typical symptoms and diverse p...
Patients with chronic heart failure who are not eligible for heart transplant and whose life expecta...
An increasing number of patients suffering from end-stage heart failure require VAD implantation as ...
Despite recent advances in treatment, the number of people with heart failure continues to grow; thi...
Severe heart failure has a poor prognosis. Mechanical circulatory support (MCS) is capable of assist...
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
Heart failure remains one of the most common causes of morbidity and mortality worldwide. The advent...
Continuous-flow left-ventricular assist devices (LVADs) have emerged as the standard of care for adv...
The shortage of appropriate donor organs and the expanding pool of patients waiting for heart transp...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/71424/1/j.1527-5299.2000.80165.x.pd
In this article, we present our experience with left ventricular assist device implantation
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. Th...
Heart transplant is the gold-standard treatment for end-stage heart failure. However, the aging of t...
Heart failure continues to be an ever-growing public health concern. The continued aging of the popu...
Heart failure is a clinical syndrome of multifactorial aetiology with typical symptoms and diverse p...
Patients with chronic heart failure who are not eligible for heart transplant and whose life expecta...
An increasing number of patients suffering from end-stage heart failure require VAD implantation as ...
Despite recent advances in treatment, the number of people with heart failure continues to grow; thi...
Severe heart failure has a poor prognosis. Mechanical circulatory support (MCS) is capable of assist...
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
Heart failure remains one of the most common causes of morbidity and mortality worldwide. The advent...
Continuous-flow left-ventricular assist devices (LVADs) have emerged as the standard of care for adv...
The shortage of appropriate donor organs and the expanding pool of patients waiting for heart transp...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/71424/1/j.1527-5299.2000.80165.x.pd
In this article, we present our experience with left ventricular assist device implantation
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. Th...
Heart transplant is the gold-standard treatment for end-stage heart failure. However, the aging of t...